High Evidence
Research Overview
SS-31 Research for Barth Syndrome
An evidence-based overview of research examining SS-31 in the context of barth syndrome. This page synthesizes findings from peer-reviewed literature.
Research Summary
Barth syndrome is caused by TAZ gene mutations affecting cardiolipin remodeling, creating a direct mechanistic rationale for SS-31. Phase 2/3 trial showed 67-meter improvement in 6-minute walk test and significant improvements in muscle strength and fatigue (n=12).
Referenced Studies
Click any PMID to view the full study on PubMed.
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. SS-31 may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.